Mateen Dalal currently works for healthcareopportunity.org as a content developer, writing valuable pieces pertaining to the healthcare industry. Having completed his graduation in electronics and telecommunication engineering, Mateen also boasts of a short-term experience in test engineering. When he isn’t penning down insightful pieces, Mateen spends time trekking across town and enjoying at the gaming zone. He can be contacted at- [email protected] | https://twitter.com/MateenDalal
IP Group plc., a UK-based intellectual property company, recently announced the agreement between its private equity firm Avacta Group and LG Chem Life Sciences, a subsidiary of South Korean …
San Francisco’s asset management firm, Asymmetry Capital Management L.P. has recently acquired 35,870 shares of retail pharmacy and health care giant, CVS Health Corp. in the Q3 for approximately …
Swiss multinational healthcare giant Roche has reportedly announced that it has received the approval by the United States Food and Drug Administration (U.S. FDA) for its Tecentriq atezolizumab regimen. …
Singapore based biotech firm Tychan has reportedly announced that its first-in-class candidate drug for treating Yellow Fever has obtained an investigatory new drug (IND) regulatory approval from Singapore’s Health …
Swedish biotech firm SciBase AB along with Swiss Institute of Allergy and Asthma Research have reportedly announced that the two are signing a formal collaboration agreement in the field …
Canada-based biopharmaceutical firm HydRx Farms Ltd. (operating as Scientus Pharma) has reportedly announced to have received the U.S. Patent Number 10,143,706 from the United States Patent and Trademark Office. …
